MFIN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Soleno Therapeutics Q1 2026 Earnings EPS Misses Estimates by 1494 Stock Holds Steady KAPA Q1 2026 Earnings EPS Misses Estimates as Development Expenses Weigh ASRT Q1 2026 Earnings Significant EPS Miss Amid Revenue Disclosure Absence MRVI Q1 2026 Earnings EPS Surprise of 12079 Drives Focus on Cost Control Amid Revenue Uncertainties KNSA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Product Growth